AGVHD
Clinical trials for AGVHD explained in plain language.
Never miss a new study
Get alerted when new AGVHD trials appear
Sign up with your email to follow new studies for AGVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to stop dangerous transplant side effect
Disease control Recruiting nowThis study is testing whether adding an experimental drug called BPC2001 to standard care can better prevent a serious complication called graft-versus-host disease (GvHD) after a stem cell transplant. The trial will enroll 50 adults with blood cancers who are receiving a transpl…
Matched conditions: AGVHD
Phase: PHASE2 • Sponsor: BioPhoenix Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Double-Donor transplant offers hope for leukemia patients lacking matches
Disease control Recruiting nowThis study is testing a new transplant method for adults with high-risk leukemia or myelodysplastic syndromes (MDS) who do not have a perfectly matched donor. It combines cells from a partially matched family donor with cells from umbilical cord blood. The goal is to see if this …
Matched conditions: AGVHD
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC